Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-7.21%
operating margin TTM
-4.42%
revenue TTM
289.90 Million
revenue per share TTM
1.57$
valuation ratios | |
|---|---|
| pe ratio | -39.91 |
| peg ratio | -0.49 |
| price to book ratio | 3.03 |
| price to sales ratio | 2.90 |
| enterprise value multiple | -563.89 |
| price fair value | 3.03 |
profitability ratios | |
|---|---|
| gross profit margin | 56.58% |
| operating profit margin | -4.42% |
| pretax profit margin | -4.43% |
| net profit margin | -7.21% |
| return on assets | -5.23% |
| return on equity | -8.7% |
| return on capital employed | -4.17% |
liquidity ratios | |
|---|---|
| current ratio | 3.04 |
| quick ratio | 2.94 |
| cash ratio | 1.67 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 27.44 |
| operating cycle | 84.29 |
| days of payables outstanding | 51.11 |
| cash conversion cycle | 33.18 |
| receivables turnover | 6.42 |
| payables turnover | 7.14 |
| inventory turnover | 13.30 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.16 |
| debt equity ratio | 0.23 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.18 |
| interest coverage | -3.34 |
| cash flow to debt ratio | -0.66 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.37 |
| cash per share | 5.16 |
| operating cash flow per share | -0.98 |
| free cash flow operating cash flow ratio | 1.40 |
| cash flow coverage ratios | -0.66 |
| short term coverage ratios | -1.09 |
| capital expenditure coverage ratio | -2.52 |
Frequently Asked Questions
When was the last time Legend Biotech Corporation (NASDAQ:LEGN) reported earnings?
Legend Biotech Corporation (LEGN) published its most recent earnings results on 11-08-2026.
What is Legend Biotech Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Legend Biotech Corporation (NASDAQ:LEGN)'s trailing twelve months ROE is -8.7%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Legend Biotech Corporation (LEGN) currently has a ROA of -5.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did LEGN's net profit margin stand at?
LEGN reported a profit margin of -7.21% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is LEGN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.04 in the most recent quarter. The quick ratio stood at 2.94, with a Debt/Eq ratio of 0.23.